Results 21 to 30 of about 173,076 (340)

Management of imatinib-resistant CML patients [PDF]

open access: yes, 2007
Imatinib has had marked impact on outcomes in chronic myelogenous leukemia (CML) patients for all stages of the disease and is endorsed by international treatment guidelines as the first line option.
Branford S   +21 more
core   +1 more source

CAR-T cell therapy followed by allogenic hematopoietic stem cell transplantation yielded comparable outcome between Ph like ALL and other high-risk ALL

open access: yesBiomarker Research, 2023
It was previously believed that patients with Ph-like ALL had poorer prognosis compared with other B-ALL subgroups due to resistance to conventional chemotherapy and lack of targeted drugs.
Hai-ping Dai   +10 more
doaj   +1 more source

Viruses associated with pneumonia in adults. [PDF]

open access: yes, 2012
Viral pneumonia, which is typically associated with disease in childhood, is increasingly recognized as causing problems in adults. Certain viruses, such as influenza virus, can attack fully immunocompetent adults, but many viruses take advantage of more-
Cesario, Thomas C
core   +1 more source

CD38-directed CAR-T cell therapy: a novel immunotherapy strategy for relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

open access: yesJournal of Hematology & Oncology, 2021
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment for acute myeloid leukemia (AML). However, most patients experience relapse after allo-HSCT, with a poor prognosis, and treatment options are limited.
Qingya Cui   +16 more
doaj   +1 more source

Hematologic Manifestations Of Rheumatic Diseases [PDF]

open access: yesJournal of Education, Health and Sport, 2018
Hetman Marcin, Kulczyński Marcin, Dobryniewska Wanda, Grzebyk Dominik, Fornal Natalia, Bracik Ewelina, Chromiec Tomasz. Hematologic manifestations of rheumatic diseases. Journal of Education, Health and Sport. 2018;8(9):1197-1206 eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1422464 http://ojs.ukw.edu.pl/index.php/johs/article/view/6041 https:
Hetman, Marcin   +6 more
openaire   +3 more sources

Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: A single institutional experience. [PDF]

open access: yes, 2015
The objectives of this study were to evaluate the effectiveness of nab-paclitaxel plus gemcitabine (NAB-P/GEM) regimen in an unselected population of patients with advanced inoperable or metastatic pancreatic cancer (PC), and to identify the prognostic ...
Basso, Smm   +5 more
core   +2 more sources

Creation and assessment of a clinical predictive calculator and mortality associated with Candida krusei bloodstream infections [PDF]

open access: yes, 2018
Background Candida krusei bloodstream infection (CK BSI) is associated with high mortality, but whether this is due to underlying comorbidities in affected patients or the organism itself is unknown.
Hsueh, Kevin   +4 more
core   +2 more sources

Murine cytomegalovirus genomic material in marrow cells; relation to altered leukocyte counts during sublethal infection of mice [PDF]

open access: yes, 1987
To investigate infection of hematopoietic cells by murine cytomegalovirus (MCMV), we used in situ hybridization to detect MCMV genomic material in marrow cells during sublethal infection of three-week-old mice.
Bale, J. F.   +4 more
core   +1 more source

Hope for hematological diseases [PDF]

open access: yesScience, 2020
Tweaking growth media helps cultured hematopoietic stem cells ...
openaire   +2 more sources

Patient‐reported physical well‐being predicts good long‐term survival of hematopoietic stem cell transplantation

open access: yesCancer Medicine
Aim This study aimed to explore the association between patient‐reported items at different time points after hematopoietic stem cell transplantation (HSCT) and long‐term survival. Methods We conducted a study with 144 allogeneic HSCT patients, following
Yin Lu   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy